Zandra Klippel
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Oncology 24
- Neutropenia and Cancer Infections 14
- Peptidase Inhibition and Analysis 6
- Cancer Treatment and Pharmacology 5
- Hematology 17
- Multiple Myeloma Research and Treatments 17
- Co-authors
- Meletios Α. Dimopoulos (9 shared papers)Anita Zahlten‐Kumeli (5 shared papers)Saad Z. Usmani (4 shared papers)David S. Siegel (6 shared papers)María‐Victoria Mateos (4 shared papers)Katja Weisel (4 shared papers)Hui Yang (4 shared papers)Xavier Leleu (2 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (5 papers)HemaSphere (3 papers)Cancer Medicine (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)
- Partner nations
- United StatesFranceGreece
In The Last Decade
Zandra Klippel
31 papers receiving 771 citations
Zandra Klippel's Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 523
- Oncology 505
- Molecular Biology 436
- Genetics 56
- Dermatology 32
Countries citing papers authored by Zandra Klippel
This map shows the geographic impact of Zandra Klippel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zandra Klippel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zandra Klippel more than expected).
Fields of papers citing papers by Zandra Klippel
This network shows the impact of papers produced by Zandra Klippel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zandra Klippel. The network helps show where Zandra Klippel may publish in the future.
Co-authors
The 25 scholars most cited alongside Zandra Klippel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2020 | 289 |
| 2 | 2019 | 83 | |
| 3 | 2017 | 58 | |
| 4 | 2016 | 34 | |
| 5 | 2019 | 34 | |
| 6 | 2016 | 31 | |
| 7 | 2014 | 30 | |
| 8 | 2017 | 30 | |
| 9 | 2020 | 26 | |
| 10 | 2016 | 25 | |
| 11 | 2019 | 22 | |
| 12 | 2016 | 21 | |
| 13 | 2015 | 21 | |
| 14 | 2020 | 13 | |
| 15 | 2017 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2018 | 9 | |
| 19 | 2016 | 5 | |
| 20 | 2014 | 4 |
About Zandra Klippel
Zandra Klippel is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 34 papers that have together received 790 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Neutropenia and Cancer Infections (14 papers), Blood disorders and treatments (9 papers), Protein Degradation and Inhibitors (8 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Treatment and Pharmacology (5 papers), Hematological disorders and diagnostics (5 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Hematology (523 citations), Oncology (505 citations), Molecular Biology (436 citations), Genetics (56 citations) and Dermatology (32 citations). Zandra Klippel has collaborated with scholars based in United States, France and Greece. Frequent co-authors include Meletios Α. Dimopoulos, Anita Zahlten‐Kumeli, Saad Z. Usmani, David S. Siegel, María‐Victoria Mateos, Katja Weisel, Hui Yang, Xavier Leleu, Ola Landgren and Hang Quach. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Cancer Medicine and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.